Dalan Animal Health

Dalan Animal Health, founded in 2018 and headquartered in Athens, Georgia, is a pioneering vaccine platform company dedicated to combating devastating bee diseases. The company's core mission is to enhance invertebrate health through sustainable solutions that benefit the global community. Dalan's flagship product is an innovative, orally delivered bee vaccine designed to protect hives from diseases such as American Foulbrood (AFB). This vaccine is ingested by the Queen Bee and subsequently passed on to larvae, ensuring comprehensive protection for the colony.

Notable figures affiliated with Dalan Animal Health include experts in entomology and veterinary sciences, although specific names are not provided. The company has attracted significant attention and investment due to its groundbreaking approach to bee health. Key achievements include the development and successful deployment of the first-of-its-kind bee vaccine, which has the potential to revolutionize apiculture and contribute to global agricultural sustainability. Dalan's impact extends beyond bee health, aiming to safeguard ecosystems and food security worldwide.